Posted by Admin | Posted in Medical Lawyers | Posted on 31-07-2009
SILVER SPRING, Md. (EGMN) A federal advisory panel has agreed that asenapine maleate, an atypical antipsychotic formulated in an immediate-release sublingual tablet, is effective and has an acceptable safety profile for the acute treatment of schizophrenia and bipolar I disorder in adults.
Posted by Admin | Posted in Medical Documents | Posted on 31-07-2009
Renu Agarwal, Suresh K Gupta, Puneet Agarwal, Rohit Saxena, Shyam S AgrawalIndian Journal of Ophthalmology 2009 57(4):257-266Glaucoma, the second leading cause of blindness, is characterized by changes in the optic disc and visual field defects. The elevated intraocular pressure was considered the prime factor responsible for the glaucomatous optic neuropathy involving death of retinal ganglion cells and their axons. Extensive investigations into the pathophysiology of glaucoma now reveal the role of multiple factors in the development of retinal ganglion cell death. A better understanding of the pathophysiological mechanisms involved in the onset and progression of glaucomatous optic neuropathy is crucial in the development of better therapeutic options. This review is an effort to summar…
Posted by Admin | Posted in Medical Lawyers | Posted on 30-07-2009
SILVER SPRING, Md. (EGMN) The majority of a Food and Drug Administration advisory panel agreed that telmisartan, currently approved for treating hypertension, should be approved for reducing the risk of cardiovascular events in patients at high risk for such events, but only if they cannot tolerate treatment with ramipril.
Posted by Admin | Posted in Medical Documents | Posted on 30-07-2009
PHPartners is the product of a collaboration of U.S. government agencies, public health organizations and health sciences libraries . The August 26 webinar class will cover the website, which will include information on current topics such as Bioterrorism, ongoing projects such as Healthy People 2010, and public health resources including promotions and statistics.
Tune in on Wednesday, Aug. 26 at 1:00MT, 2:00CT for the MLA CE class PHPartners presented by Marty Magee.
This online training is FREE, and requires no registration. All you need is a computer with Internet access and a phone. You’ll sign in as a guest, enter your phone number when prompted and the system will call you! Access it by going to: https://webmeeting.nih.gov/mcr.
To receive Medical Library Association Continuin…
Posted by Admin | Posted in Medical Lawyers | Posted on 29-07-2009
The National Heart, Lung, and Blood Institute on July 7 prematurely stopped a trial testing the drug sildenafil as treatment for pulmonary hypertension in adults with sickle cell disease.
Posted by Admin | Posted in Medical Lawyers | Posted on 27-07-2009
Some patients with stage IIIA nonsmall cell lung cancer may benefit from trimodality treatment in which surgery follows standard chemotherapy and radiotherapy, according to the results of a large phase III, randomized, controlled trial led by the Radiation Therapy Oncology Group in Philadelphia.
Posted by Admin | Posted in Medical Lawyers | Posted on 25-07-2009
Another diagnostic test for the 2009 H1N1 influenza virus received an Emergency Use Authorization by the Food and Drug Administration on July 24.
Posted by Admin | Posted in Medical Stuff | Posted on 24-07-2009
Posted by Admin | Posted in Medical Lawyers | Posted on 24-07-2009
GAITHERSBURG, Md. (EGMN) A Food and Drug Administration advisory panel agreed that it is appropriate for the agency to license vaccines against the novel 2009 H1N1 influenza virus with the same approach used to license the annual seasonal influenza vaccine as a strain change.